60
Participants
Start Date
October 10, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 29, 2036
Minnesota Living with Heart Failure Questionnaire
Self-administered, validated questionnaire to assess symptoms of heart failure
Echocardiogram
Resting transthoracic echocardiogram to exclude valvular pathology and the assess indices of systolic and diastolic function and speckle tracking for strain
Six-minute walk test
Standardised, objective assessment of exercise capacity
Manganese-enhanced MRI and 31-P magnetic resonance spectroscopy
Using a 3-Tesla scanner, 31P magnetic resonance spectroscopy will be performed to obtain information regarding cardiac energetics. An intravenous infusion of manganese dipyridoxyl diphosphate (mangafodipir, MnDPDP) will be commenced at a rate of 1mL/min using a dose of 5µmol/kg (0.1mL/kg).
Cardiovascular magnetic resonance scan
Scan including adenosine stress perfusion
Blood tests
Full blood count, Urea and electrolytes, Liver function tests, Glucose and HbA1c, Insulin and C-peptide, NTproBNP, High sensitive troponin I, storage of plasma for future analyses
RECRUITING
University of Leicester, Leicester
University of Leicester
OTHER